CEO, A. Stotz Investment Research

Dr. Andrew Stotz, CFA

Quantamental Investing to beat Benchmarks

A. Stotz Investment Research

We pick stocks. We construct portfolios. All our effort is focused on how to better pick stocks and construct portfolios. We serve fund management companies, family offices, and high net worth individuals.

Equity Bottom-Up

Indah Kiat Pulp & Paper Tbk / Equity Bottom-Up

<ul>
<li>Good price momentum, low correlation with Western stock markets, and good growth in core profit relative to its sector</li>
<li>Indonesia’s largest pulp and paper-related products manufacturer by sales should continue to benefit from continued high pulp price due to tight global supply following a suspension of capacity by the Chinese</li>
<li>Asian demand should remain solid at a CAGR of 5% until 2018, while announced capacity expansions from global paper players aren’t expected until 2020, 88% of INKP’s sales were in Asia in 2017</li>
<li>INKP has shown strong improvement in gross profit margin and current PE is still undemanding relative to global peers</li>
<li>Risk: China ramps up supply, lower demand from downstream players</li>
</ul>


Good price momentum, low correlation with Western stock markets, and good growth in core profit relative to its sector
Indonesia’s largest pulp and paper-related products manufacturer by sales should continue to benefit from continued high pulp price due to tight global supply following a suspension of capacity by the Chinese
Asian demand should remain solid at a CAGR of 5% until 2018, while announced capacity expansions from global paper players aren’t expected until 2020, 88% of INKP’s sales were in Asia in 2017
INKP has shown strong improvement in gross profit margin and current PE is still undemanding relative to global peers
Risk: China ramps up supply, lower demand from downstream players


INKP (INKP IJ): Valuation Still Undemanding Relative to Global Peers

Technical Analyst, Vermilion Research

Joe Jasper

Technical Analyst

Technical and Quantitative Research

Vermilion Research

Vermilion’s objective is to deliver timely, actionable, and unique technical research to professional investors through the application of our various technical indicators.

Our research strategists seek to highlight securities which we believe are at major inflection points, based on our various technical and quantitative indicators, and offer asymmetric risk/return profiles. Our unique research methodology, centered on relative strength, enables our strategists to deliver superior investment recommendations.

Our process begins by organizing the universe of actively traded stocks into discrete sectors, then into industry groups. We then apply our technical and quantitative tools to identify developing price trends. Once attractive trends are identified within a selected sector or group, we screen for individual stocks which we believe offer the best risk/reward profile. We provide a historical perspective that often reveals, through our long-term charts, how price patterns often repeat themselves over time.

Technical Analysis

In our June International Strategy, we explore the following themes in detail:<ul><li> Early-stage MSCI ACWI uptrend combined with constructive breadth indicators helps support our increasingly bullish outlook.</li><li>Cyclical and growth Sectors are leadership. Within Consumer Discretionary we highlight Restaurants, and within Technology we highlight Semiconductors.</li><li>Within International Developed, overweight small-caps, Japan, and Norway.</li><li>Broad Emerging Market relative strength is deteriorating. Be selective.</li></ul>

In our June International Strategy, we explore the following themes in detail: Early-stage MSCI ACWI uptrend combined with constructive breadth indicators helps support our increasingly bullish outlook.Cyclical and growth Sectors are leadership. Within Consumer Discretionary we highlight Restaurants, and within Technology we highlight Semiconductors.Within International Developed, overweight small-caps, Japan, and Norway.Broad Emerging Market relative strength is deteriorating. Be selective.

Global Equity Strategy: ACWI and EM Testing Support

Over the past several weeks we have outlined the case for our increasingly bullish outlook, noting that market internals remain favorable and S&amp;P 500 and MSCI ACWI price trends are showing evidence of early-stage uptrend formations. In today’s report we provide an overview of international markets and highlight our top recommendations.

Over the past several weeks we have outlined the case for our increasingly bullish outlook, noting that market internals remain favorable and S&amp;P 500 and MSCI ACWI price trends are showing evidence of early-stage uptrend formations. In today’s report we provide an overview of international markets and highlight our top recommendations.

Price and relative strength trends continue to improve for our international equal-weight Health Care Sector. We recommend adding exposure, and provide charts on numerous actionable stocks across global markets. We also highlight actionable stocks within Materials, beyond metals &amp; mining stocks, that are outperforming.

Price and relative strength trends continue to improve for our international equal-weight Health Care Sector. We recommend adding exposure, and provide charts on numerous actionable stocks across global markets. We also highlight actionable stocks within Materials, beyond metals &amp; mining stocks, that are outperforming. 

Global Strategy: Opportunities in Health Care & Materials Stocks

MSCI Emerging Markets Index / Technical Analysis

Recent USD strength has weighed on EM’s relative performance. Given (1) strength in commodity prices (sans precious metals), (2) the potential for some backing-and-filling of the USD, and (3) MSCI EM price and relative strength support levels continuing to hold, we see recent weakness as a buying opportunity.  The MSCI BRIC index has reasserted its leadership status. In addition to China, fellow BRIC countries Brazil and India exhibit attractive setups, while Chile’sIPSA also presents opportunities. Today’s report includes a wide variety of bottom-up recommendations across the EM universe, spanning most sectors and all market capitalizations.

Recent USD strength has weighed on EM’s relative performance. Given (1) strength in commodity prices (sans precious metals), (2) the potential for some backing-and-filling of the USD, and (3) MSCI EM price and relative strength support levels continuing to hold, we see recent weakness as a buying opportunity.  The MSCI BRIC index has reasserted its leadership status. In addition to China, fellow BRIC countries Brazil and India exhibit attractive setups, while Chile’sIPSA also presents opportunities. Today’s report includes a wide variety of bottom-up recommendations across the EM universe, spanning most sectors and all market capitalizations.

Emerging Markets Strategy: Attractive Setups in China, Brazil, India, and Chile

Brazil

Fibria Celulose S.A., together with its subsidiaries, engages in the production, sale, and export of short fiber pulp. It primarily provides bleached eucalyptus kraft pulp for use in manufacturing toilet paper, uncoated, and coated paper.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Fibria Celulose SA (FIBR3 BZ)

INKP (INKP IJ): Valuation Still Undemanding Relative to Global Peers

Good price momentum, low correlation with Western stock markets, and good growth in core profit relative to its sector Indonesia’s largest pulp...

A. Stotz Investment Research

Global Equity Strategy: ACWI and EM Testing Support

In our June International Strategy, we explore the following themes in detail: Early-stage MSCI ACWI uptrend combined with constructive breadth...

Vermilion Research

Global Equity Markets Overview

Over the past several weeks we have outlined the case for our increasingly bullish outlook, noting that market internals remain favorable and...

Vermilion Research

Global Strategy: Opportunities in Health Care & Materials Stocks

Price and relative strength trends continue to improve for our international equal-weight Health Care Sector.We recommend adding exposure, and...

Vermilion Research

Emerging Markets Strategy: Attractive Setups in China, Brazil, India, and Chile

Recent USD strength has weighed on EM’s relative performance. Given (1) strength in commodity prices (sans precious metals), (2) the potential for...

Vermilion Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)